Acrivon Therapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Acrivon Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Acrivon Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Acrivon Therapeutics by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $23k | 11k | 2.03 |
| 2024-12-31 | $74k | 12k | 6.02 |
| 2024-09-30 | $79k | 11k | 7.00 |
| 2024-06-30 | $30k | 5.1k | 5.80 |
| 2024-03-31 | $32k | 4.5k | 7.15 |
| 2023-12-31 | $10k | 2.0k | 4.92 |
| 2023-09-30 | $2.2k | 230 | 9.56 |
| 2023-03-31 | $2.6k | 202 | 12.69 |